Exelixis Inc (NAS:EXEL)
$ 35.92 0.07 (0.2%) Market Cap: 10.26 Bil Enterprise Value: 9.21 Bil PE Ratio: 23.03 PB Ratio: 4.51 GF Score: 91/100

Exelixis Inc at Biotechnology Industry Organization (BIO) CEO & Investor Conference Transcript

Feb 11, 2020 / 07:00PM GMT
Release Date Price: $19.39 (+0.94%)
Nareg Sagherian;Biotechnology Innovation Organization;Managing Director of Investor Relations

I'm, Nareg Sagherian, Managing Director of Investor Relations and Programming here at Bio. Welcome to the fireside chat with Michael Morrissey, President and Chief Executive Officer at Exelixis. Visit the Bio Boulevard to learn more about Bio's new podcast, featuring biotechnology breakthroughs, the global problems they solve and the stories of patients whose lives have been changed forever by our work. You can also download our first annual diversity and inclusion report at right-mix-matters.org.

We'd like to take a moment to acknowledge the General Sponsors that support our conference. I'll also leave our disclosure statement on the screen for a moment.

So without further ado, I'm going to introduce our moderator. Please help me in welcoming Asthika Goonewardene from SunTrust Robinson and Humphrey.

Asthika Goonewardene
SunTrust Robinson Humphrey, Inc., Research Division - Research Analyst

Excellent. Thank you, Nareg. Hi

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot